Thrivent Financial For Lutherans Merck & Co., Inc. Transaction History

Thrivent Financial For Lutherans

  • $50.8 Billion
  • Q3 2025

A detailed history of Thrivent Financial For Lutherans transactions in Merck & Co., Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 2,379,666 shares of MRK stock, worth $221 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
2,379,666
Previous 2,221,342 7.13%
Holding current value
$221 Million
Previous $176 Million 13.58%
% of portfolio
0.39%
Previous 0.38%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
BUY
$77.6 - $87.37 $12.3 Million - $13.8 Million
158,324 Added 7.13%
2,379,666 $200 Million
Q2 2025

Aug 26, 2025
BUY
$73.47 - $87.12 $55.4 Million - $65.7 Million
753,681 Added 51.35%
2,221,342 $176 Million
Q2 2025

Aug 11, 2025
SELL
$73.47 - $87.12 $71.5 Million - $84.8 Million
-973,646 Reduced 89.86%
109,914 $8.7 Million
Q1 2025

Aug 26, 2025
BUY
$83.01 - $101.02 $113 Million - $137 Million
1,357,747 Added 1235.28%
1,467,661 $132 Million
Q1 2025

May 13, 2025
SELL
$83.01 - $101.02 $38 Million - $46.2 Million
-457,779 Reduced 29.7%
1,083,560 $97.9 Million
Q4 2024

Feb 10, 2025
SELL
$96.31 - $114.76 $28.5 Million - $34 Million
-296,015 Reduced 16.11%
1,541,339 $153 Million
Q3 2024

Nov 07, 2024
BUY
$111.15 - $128.97 $6.9 Million - $8 Million
62,047 Added 3.5%
1,837,354 $209 Million
Q2 2024

Aug 13, 2024
BUY
$123.8 - $132.96 $7.64 Million - $8.2 Million
61,677 Added 3.6%
1,775,307 $220 Million
Q1 2024

May 14, 2024
SELL
$113.24 - $131.95 $7.85 Million - $9.15 Million
-69,329 Reduced 3.89%
1,713,630 $226 Million
Q4 2023

Feb 14, 2024
SELL
$100.18 - $109.02 $16.5 Million - $17.9 Million
-164,613 Reduced 8.45%
1,782,959 $194 Million
Q3 2023

Nov 14, 2023
SELL
$102.95 - $114.33 $15.4 Million - $17.1 Million
-149,575 Reduced 7.13%
1,947,572 $201 Million
Q2 2023

Aug 14, 2023
SELL
$108.61 - $118.38 $2.09 Million - $2.28 Million
-19,230 Reduced 0.91%
2,097,147 $242 Million
Q1 2023

May 17, 2023
SELL
$102.94 - $114.86 $21.3 Million - $23.8 Million
-207,093 Reduced 8.91%
2,116,377 $225 Million
Q4 2022

Feb 08, 2023
SELL
$87.44 - $112.11 $18.5 Million - $23.7 Million
-211,381 Reduced 8.34%
2,323,470 $258 Million
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $38.5 Million - $43.3 Million
455,777 Added 21.92%
2,534,851 $218 Million
Q2 2022

Aug 16, 2022
BUY
$83.49 - $94.64 $1.86 Million - $2.11 Million
22,295 Added 1.08%
2,079,074 $190 Million
Q1 2022

May 13, 2022
SELL
$73.51 - $82.4 $23.3 Million - $26.1 Million
-317,177 Reduced 13.36%
2,056,779 $169 Million
Q4 2021

Feb 16, 2022
BUY
$72.28 - $90.54 $23.2 Million - $29.1 Million
321,589 Added 15.67%
2,373,956 $182 Million
Q3 2021

Nov 15, 2021
BUY
$71.68 - $78.83 $3.45 Million - $3.8 Million
48,143 Added 2.4%
2,052,367 $154 Million
Q2 2021

Sep 24, 2021
BUY
$70.31 - $77.77 $2.24 Million - $2.48 Million
31,923 Added 1.62%
2,004,224 $156 Million
Q2 2021

Aug 19, 2021
SELL
$70.31 - $77.77 $2.5 Million - $2.77 Million
-35,609 Reduced 1.77%
1,972,301 $153 Million
Q1 2021

May 17, 2021
BUY
$68.86 - $81.11 $6.06 Million - $7.14 Million
88,009 Added 4.58%
2,007,910 $155 Million
Q4 2020

Feb 16, 2021
SELL
$71.77 - $79.65 $11.3 Million - $12.6 Million
-157,940 Reduced 7.6%
1,919,901 $157 Million
Q3 2020

Nov 10, 2020
SELL
$73.18 - $82.95 $2.37 Million - $2.69 Million
-32,444 Reduced 1.54%
2,077,841 $172 Million
Q2 2020

Aug 12, 2020
BUY
$70.42 - $80.13 $4.41 Million - $5.02 Million
62,625 Added 3.06%
2,110,285 $163 Million
Q1 2020

May 15, 2020
SELL
$63.36 - $87.82 $22.1 Million - $30.6 Million
-348,327 Reduced 14.54%
2,047,660 $158 Million
Q4 2019

Feb 13, 2020
BUY
$77.58 - $87.54 $78,976 - $89,115
1,018 Added 0.04%
2,395,987 $218 Million
Q3 2019

Nov 14, 2019
SELL
$76.08 - $82.93 $13.4 Million - $14.6 Million
-176,097 Reduced 6.85%
2,394,969 $202 Million
Q2 2019

Aug 13, 2019
BUY
$69.84 - $81.59 $5.42 Million - $6.33 Million
77,573 Added 3.11%
2,571,066 $216 Million
Q1 2019

May 14, 2019
SELL
$69.58 - $79.36 $69 - $79
-1 Reduced -0.0%
2,493,493 $207 Million
Q4 2018

Feb 15, 2019
BUY
$65.24 - $75.71 $6.01 Million - $6.97 Million
92,119 Added 3.84%
2,493,494 $190 Million
Q3 2018

Nov 15, 2018
BUY
$57.69 - $67.84 $3.73 Million - $4.38 Million
64,599 Added 2.76%
2,401,375 $170 Million
Q2 2018

Aug 14, 2018
SELL
$50.83 - $59.72 $5.64 Million - $6.63 Million
-110,995 Reduced 4.53%
2,336,776 $142 Million
Q1 2018

May 08, 2018
SELL
$50.96 - $59.23 $7.4 Million - $8.6 Million
-145,234 Reduced 5.6%
2,447,771 $133 Million
Q4 2017

Feb 14, 2018
BUY
$51.62 - $61.64 $6.73 Million - $8.03 Million
130,280 Added 5.29%
2,593,005 $146 Million
Q3 2017

Nov 14, 2017
BUY
$58.67 - $63.13 $144 Million - $155 Million
2,462,725
2,462,725 $158 Million

Others Institutions Holding MRK

# of Institutions
3,875
Shares Held
1.9B
Call Options Held
30.1M
Put Options Held
27.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email